| __timestamp | HUTCHMED (China) Limited | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 91813000 | 2819557000 |
| Thursday, January 1, 2015 | 178203000 | 4103728000 |
| Friday, January 1, 2016 | 216080000 | 4860427000 |
| Sunday, January 1, 2017 | 241203000 | 5872227000 |
| Monday, January 1, 2018 | 214109000 | 6710800000 |
| Tuesday, January 1, 2019 | 204890000 | 7863400000 |
| Wednesday, January 1, 2020 | 227976000 | 8497100000 |
| Friday, January 1, 2021 | 356128000 | 16071700000 |
| Saturday, January 1, 2022 | 426409000 | 12172900000 |
| Sunday, January 1, 2023 | 837999000 | 13117200000 |
| Monday, January 1, 2024 | 14202000000 |
Cracking the code
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market influence. Over the past decade, Regeneron Pharmaceuticals, Inc. and HUTCHMED (China) Limited have showcased contrasting trajectories in their annual revenue growth.
Regeneron, a leader in the biotech industry, has seen its revenue soar by approximately 365% from 2014 to 2023, reaching a peak of $13.1 billion in 2023. This growth underscores Regeneron's robust pipeline and successful commercialization strategies. In contrast, HUTCHMED, while experiencing a more modest growth of around 813%, increased its revenue from $91 million in 2014 to $838 million in 2023. This reflects HUTCHMED's expanding footprint in the global market, particularly in oncology.
These figures highlight the diverse strategies and market conditions influencing biotech companies, offering valuable insights for investors and industry analysts alike.
AbbVie Inc. and HUTCHMED (China) Limited: A Comprehensive Revenue Analysis
Vertex Pharmaceuticals Incorporated vs HUTCHMED (China) Limited: Examining Key Revenue Metrics
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Alnylam Pharmaceuticals, Inc.?
Who Generates More Revenue? Regeneron Pharmaceuticals, Inc. or Viatris Inc.
Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation: Examining Key Revenue Metrics
Regeneron Pharmaceuticals, Inc. or Corcept Therapeutics Incorporated: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Merus N.V.?
Regeneron Pharmaceuticals, Inc. vs Geron Corporation: Examining Key Revenue Metrics
Regeneron Pharmaceuticals, Inc. or Novavax, Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited?
Jazz Pharmaceuticals plc and HUTCHMED (China) Limited: A Comprehensive Revenue Analysis
Lantheus Holdings, Inc. or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?